Literature DB >> 19182440

Suppressive effect of Siraitia grosvenorii extract on dicyclanil-promoted hepatocellular proliferative lesions in male mice.

Sayaka Matsumoto1, Meilan Jin, Yasuaki Dewa, Jihei Nishimura, Mitsuyoshi Moto, Yuji Murata, Makoto Shibutani, Kunitoshi Mitsumori.   

Abstract

Dicyclanil (DC) generates reactive oxygen species (ROS) due to Cyp1a1 induction, and DNA damage caused by oxidative stress is probably involved in hepatocarcinogenesis in mice. To clarify the modifying effect of the Siraitia grosvenorii extract (SGE), which has antioxidative properties, we employed a 2-stage liver carcinogenesis model in partially hepatectomized male ICR mice. Mice maintained on diet containing DC at a concentration of 1,500 ppm for 9 weeks after a single intraperitoneal injection of diethylnitrosamine (DEN) at a dose of 30 mg/kg and they were given water containing 2,500 ppm of SGE for 11 weeks including 2 weeks as pre-administration on DC. SGE inhibited the induction of gamma-glutamyltranspeptidase-positive hepatocytes, lipid peroxidation, and gene expression of Cyp1a1, all of which were caused by DC. To examine whether SGE indirectly inhibits Cyp1a1 expression induced by inhibition of aryl hydrocarbon receptor (Ahr)-mediated signal transduction caused by DC, mice with high (C57BL/6J mice) and low affinities (DBA/2J mice) to Ahr were given DC-containing diet and/or SGE-containing tap water for 2 weeks. Cyp1a1 gene expression was significantly lower in C57BL/6J mice administered DC + SGE than in C57BL/6J mice administered DC alone; there was no difference in the Cyp1a1 expression between DBA/2J mice administered DC + SGE and DC alone. These results suggest that SGE suppresses the induction of Cyp1a1, leading to inhibition of ROS generation and consequently inhibited hepatocarcinogenesis, probably due to suppression of Ahr activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182440     DOI: 10.2131/jts.34.109

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  5 in total

Review 1.  Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals.

Authors:  Elizabeth M Williamson; Xinmin Liu; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2020-02-06       Impact factor: 8.739

Review 2.  Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.

Authors:  Giuseppe Castello; Susan Costantini; Stefania Scala
Journal:  J Transl Med       Date:  2010-11-03       Impact factor: 5.531

3.  Effects of Siraitia grosvenorii Fruits Extracts on Physical Fatigue in Mice.

Authors:  Da-Duo Liu; Xue-Wu Ji; Rong-Wei Li
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 4.  The Fruits of Siraitia grosvenorii: A Review of a Chinese Food-Medicine.

Authors:  Xue Gong; Namuhan Chen; Kai Ren; Junying Jia; Kunhua Wei; Le Zhang; Ying Lv; Jianhua Wang; Minhui Li
Journal:  Front Pharmacol       Date:  2019-11-22       Impact factor: 5.810

5.  Exploration of the profile-effect relationship of Siraitia grosvenorii aqueous extracts related to their laxative effect on the basis of gray correlation analysis.

Authors:  Wei Dong; Jia Zeng; Qin Wang; Xin Jiang; Ting Huang
Journal:  BMC Complement Med Ther       Date:  2021-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.